跳至主要内容
临床试验/NCT06372288
NCT06372288招募中不适用

Theta Burst Transcranial Magnetic Stimulation for the Treatment of Methamphetamine Use Disorder

Carilion Clinic2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年12月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Stimulant Craving Questionnaire (STCQ)

研究概览

简要总结

This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.

详细描述

Patients who meet criteria for the study and who agree to participate in the research study will be randomized to an arm of the study by chance (like tossing a coin). The chance of receiving TMS or sham-TMS is equal. They will be enrolled in either the TMS or sham-TMS group (both groups involve 5 TMS or sham-TMS sessions). The study doctor and the participant will not know whether they are in the TMS or sham-TMS group. The purpose of this study is to determine if TMS is a potential treatment for methamphetamine use disorder. TMS is a non-invasive technique that uses magnetic pulses to temporarily stimulate specific brain areas in awake people (without the need for surgery, anesthetic, or other invasive procedures). This study will test whether a specific type of TMS (intermittent theta burst) over the forehead can produce a reduction in things that may prompt you to want to use methamphetamines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

One study personnel not involved in participant interventions will be unblinded and will randomize participants and confirm the set up of the device for the session prior to the blinded study personnel interacting with the participant. Both the participant and the blinded study personnel will not know which group the participant will be part of throughout the study sessions.

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals actively struggling with Methamphetamine Use Disorder
  • Must be currently enrolled in Carilion Clinic Office Based Addiction Treatment (OBAT) program

排除标准

  • Individuals currently struggling with alcohol use and/or benzodiazepine use

结局指标

主要结局

Stimulant Craving Questionnaire (STCQ)

时间窗: Baseline/Visit 2, daily during iTBS/Sham-TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS

Self-rated cravings for stimulants

Urine Drug Screen (UDS)

时间窗: Baseline/Visit 2, day 5 of iTBS/Sham TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS

Urine drug screens

次要结局

  • Clinical Global Impression - Improvement (CGI-I)(Baseline/Visit 2, day 5 of iTBS/Sham TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS)
  • Clinical Global Impression - Severity (CGI-S)(Screening/Visit 1)
  • Montgomery Asberg Depression Rating Scale (MADRS)(Screening/Visit 1, Baseline/Visit 2, day 5 of iTBS/Sham TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS)
  • Generalized Anxiety Disorder-7 (GAD-7)(Screening/Visit1 and day 5 of iTBS/Sham TMS)
  • Patient Health Questionnaire-9 (PHQ-9)(Screening/Visit 1 and day 5 of iTBS/Sham TMS)
  • Hamilton Anxiety Scale (HAM-A)(Baseline/Visit 2, day 5 of iTBS/Sham TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS)
  • Quality - Life Enjoyment Scale - Questionnaire (Q-LES-Q)(Baseline/Visit 2, day 5 of iTBS/Sham TMS, 3 days after-, 1 week after-, 2 weeks-after, and one month after completion of iTBS/Sham TMS)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sooraj John

Physician

Carilion Clinic

研究点 (2)

Loading locations...

相似试验